Cytomegalovirus Retinitis: A Review

被引:104
作者
Port, Alexander D. [1 ]
Orlin, Anton [1 ]
Kiss, Szilard [1 ]
Patel, Sarju [1 ]
D'Amico, Donald J. [1 ]
Gupta, Mrinali P. [1 ]
机构
[1] New York Presbyterian Hosp, Dept Ophthalmol, Weill Cornell Med Coll, New York, NY USA
关键词
cytomegalovirus; retinitis; immune recovery uveitis; IMMUNE RECOVERY UVEITIS; ACTIVE ANTIRETROVIRAL THERAPY; RHEGMATOGENOUS RETINAL-DETACHMENT; FROSTED BRANCH ANGIITIS; CYSTOID MACULAR EDEMA; VISUAL-ACUITY LOSS; CLINICAL-OUTCOMES; UNITED-STATES; RISK-FACTORS; INTRAVITREOUS TRIAMCINOLONE;
D O I
10.1089/jop.2016.0140
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Cytomegalovirus (CMV) is a ubiquitous DNA herpes virus that causes significant morbidity and mortality in immunocompromised individuals. CMV retinitis is a potentially blinding manifestation of CMV infection that was commonly seen in advanced acquired immunodeficiency syndrome (AIDS) in the era before modern combination antiretroviral therapy era, but is also recognized in patients with immune deficiency from multiple causes. The advent of and advances in antiretroviral therapies for human immunodeficiency virus have decreased the incidence of CMV retinitis by over 90% among AIDS patients, and improved visual outcomes in those affected. The diagnosis is generally a clinical one, and treatment modalities include systemic and intravitreal antiviral medications. Retinal detachment and immune recovery uveitis are sight-threatening complications of CMV retinitis that require specific treatments.
引用
收藏
页码:224 / 234
页数:11
相关论文
共 102 条
[31]  
Holbrook JT, 2003, ARCH OPHTHALMOL-CHIC, V121, P99
[32]   AIDS and ophthalmology: The first quarter century [J].
Holland, Gary N. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 145 (03) :397-408
[33]   Characteristics of untreated AIDS-related cytomegalovirus retinitis. I. Findings before the era of highly active antiretroviral therapy (1988 to 1994) [J].
Holland, Gary N. ;
Vaudaux, Jean D. ;
Jeng, Samuel M. ;
Yu, Fei ;
Goldenberg, David T. ;
Folz, Ina-Caren ;
Cumberland, William G. ;
Mccannel, Colin A. ;
Helm, Craig J. ;
Hardy, W. David .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 145 (01) :5-11
[34]   PROGRESSION RATES OF CYTOMEGALOVIRUS RETINOPATHY IN GANCICLOVIR-TREATED AND UNTREATED PATIENTS [J].
HOLLAND, GN ;
SHULER, JD .
ARCHIVES OF OPHTHALMOLOGY, 1992, 110 (10) :1435-1442
[35]  
HOLLAND GN, 1983, OPHTHALMOLOGY, V90, P859
[36]   Fluocinolone Acetonide Implant (Retisert) for Chronic Cystoid Macular Edema in Two Patients with AIDS and a History of Cytomegalovirus Retinitis [J].
Hu, Jianmin ;
Coassin, Marco ;
Stewart, Jay M. .
OCULAR IMMUNOLOGY AND INFLAMMATION, 2011, 19 (03) :206-209
[37]  
JABS DA, 1992, NEW ENGL J MED, V326, P213, DOI 10.1056/NEJM199201233260401
[38]   Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis [J].
Jabs, DA ;
Enger, C ;
Forman, M ;
Dunn, JP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) :2240-2244
[39]   Cytomegalovirus retinitis and viral resistance: Ganciclovir resistance [J].
Jabs, DA ;
Enger, C ;
Dunn, JP ;
Forman, M .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (03) :770-773
[40]   Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis [J].
Jabs, DA ;
Martin, BK ;
Forman, MS ;
Hubbard, L ;
Dunn, JP ;
Kempen, JH ;
Davis, JL ;
Weinberg, DV .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 135 (01) :26-34